(Q39200129)

9 September 2017

title

Design, synthesis and biological evaluation of indolizine derivatives as HIV-1 VIF-ElonginC interaction inhibitors (English)

1 reference

9 September 2017

Wenlin Huang

1

1 reference

9 September 2017

Tao Zuo

2

1 reference

9 September 2017

Hongwei Jin

3

1 reference

9 September 2017

Zhenming Liu

4

1 reference

9 September 2017

Zhenjun Yang

5

1 reference

9 September 2017

Xianghui Yu

6

1 reference

9 September 2017

Liangren Zhang

7

1 reference

9 September 2017

Lihe Zhang

8

1 reference

9 September 2017

publication date

3 February 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

17

1 reference

9 September 2017

issue

2

1 reference

9 September 2017

page(s)

221-243

1 reference

https://scigraph.springernature.com/pub.10.1007/s11030-013-9424-3

9 September 2017

exact match

0 references

cites work

The prevalence of antiretroviral drug resistance in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naïve HIV-infected individuals from 40 United States cities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

Novel approaches to inhibiting HIV-1 replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

Novel targets for HIV therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

DNA deamination mediates innate immunity to retroviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

A zinc-binding region in Vif binds Cul5 and determines cullin selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

Small-molecule inhibition of HIV-1 Vif.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

Baculiferins A-O, O-sulfated pyrrole alkaloids with anti-HIV-1 activity, from the Chinese marine sponge Iotrochota baculifera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

SAR and Lead Optimization of an HIV-1 Vif-APOBEC3G Axis Inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

Recent progress in synthesis and bioactivity studies of indolizines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

Molecular insight into the conformational dynamics of the Elongin BC complex and its interaction with HIV-1 Vif.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9424-3

Drug resistance mutations in HIV-1.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23378232

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Three-dimensional structure of HIV-1 VIF constructed by comparative modeling and the function characterization analyzed by molecular dynamics simulation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23378232

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11030-013-9424-3

1 reference

9 September 2017

1 reference